Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney

Yuhki Koga, Akinobu Matsuzaki, Aiko Suminoe, Miho Hatano, Yusuke Saito, Yoshiaki Kinoshita, Tatsuro Tajiri, Tomoaki Taguchi, Kenichi Kouhashi, Yoshinao Oda, Masazumi Tsuneyoshi, Toshiro Hara

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

A 5-month-old male with stage II malignant rhabdoid tumor of the kidney (MRTK) and a 24-month-old male with stage III MRTK were treated with surgical resection of tumors and chemotherapy of alternating ICE (ifosfamide, carboplatin, and etoposide) and VDC (vincristine, doxorubicin, and cyclophosphamide), followed by highdose chemotherapy using etoposide, carboplatin, and melphalan with autologous hematopoietic stem cell transplantation (SCT). Two patients have been alive without any evidence of disease for 30 and 37 months after diagnosis, respectively, and require no medication. Consolidation with SCT should be further studies for selected patients with high-risk MRTK.

Original languageEnglish
Pages (from-to)888-890
Number of pages3
JournalPediatric Blood and Cancer
Volume52
Issue number7
DOIs
Publication statusPublished - Jul 1 2009

Fingerprint

Rhabdoid Tumor
Peripheral Blood Stem Cell Transplantation
Carboplatin
Etoposide
Kidney
Survival
Drug Therapy
Ifosfamide
Melphalan
Hematopoietic Stem Cell Transplantation
Stem Cell Transplantation
Vincristine
Doxorubicin
Cyclophosphamide
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney. / Koga, Yuhki; Matsuzaki, Akinobu; Suminoe, Aiko; Hatano, Miho; Saito, Yusuke; Kinoshita, Yoshiaki; Tajiri, Tatsuro; Taguchi, Tomoaki; Kouhashi, Kenichi; Oda, Yoshinao; Tsuneyoshi, Masazumi; Hara, Toshiro.

In: Pediatric Blood and Cancer, Vol. 52, No. 7, 01.07.2009, p. 888-890.

Research output: Contribution to journalArticle

Koga, Yuhki ; Matsuzaki, Akinobu ; Suminoe, Aiko ; Hatano, Miho ; Saito, Yusuke ; Kinoshita, Yoshiaki ; Tajiri, Tatsuro ; Taguchi, Tomoaki ; Kouhashi, Kenichi ; Oda, Yoshinao ; Tsuneyoshi, Masazumi ; Hara, Toshiro. / Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney. In: Pediatric Blood and Cancer. 2009 ; Vol. 52, No. 7. pp. 888-890.
@article{23458a54207c4e1bb6d796a517ac7103,
title = "Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney",
abstract = "A 5-month-old male with stage II malignant rhabdoid tumor of the kidney (MRTK) and a 24-month-old male with stage III MRTK were treated with surgical resection of tumors and chemotherapy of alternating ICE (ifosfamide, carboplatin, and etoposide) and VDC (vincristine, doxorubicin, and cyclophosphamide), followed by highdose chemotherapy using etoposide, carboplatin, and melphalan with autologous hematopoietic stem cell transplantation (SCT). Two patients have been alive without any evidence of disease for 30 and 37 months after diagnosis, respectively, and require no medication. Consolidation with SCT should be further studies for selected patients with high-risk MRTK.",
author = "Yuhki Koga and Akinobu Matsuzaki and Aiko Suminoe and Miho Hatano and Yusuke Saito and Yoshiaki Kinoshita and Tatsuro Tajiri and Tomoaki Taguchi and Kenichi Kouhashi and Yoshinao Oda and Masazumi Tsuneyoshi and Toshiro Hara",
year = "2009",
month = "7",
day = "1",
doi = "10.1002/pbc.21958",
language = "English",
volume = "52",
pages = "888--890",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney

AU - Koga, Yuhki

AU - Matsuzaki, Akinobu

AU - Suminoe, Aiko

AU - Hatano, Miho

AU - Saito, Yusuke

AU - Kinoshita, Yoshiaki

AU - Tajiri, Tatsuro

AU - Taguchi, Tomoaki

AU - Kouhashi, Kenichi

AU - Oda, Yoshinao

AU - Tsuneyoshi, Masazumi

AU - Hara, Toshiro

PY - 2009/7/1

Y1 - 2009/7/1

N2 - A 5-month-old male with stage II malignant rhabdoid tumor of the kidney (MRTK) and a 24-month-old male with stage III MRTK were treated with surgical resection of tumors and chemotherapy of alternating ICE (ifosfamide, carboplatin, and etoposide) and VDC (vincristine, doxorubicin, and cyclophosphamide), followed by highdose chemotherapy using etoposide, carboplatin, and melphalan with autologous hematopoietic stem cell transplantation (SCT). Two patients have been alive without any evidence of disease for 30 and 37 months after diagnosis, respectively, and require no medication. Consolidation with SCT should be further studies for selected patients with high-risk MRTK.

AB - A 5-month-old male with stage II malignant rhabdoid tumor of the kidney (MRTK) and a 24-month-old male with stage III MRTK were treated with surgical resection of tumors and chemotherapy of alternating ICE (ifosfamide, carboplatin, and etoposide) and VDC (vincristine, doxorubicin, and cyclophosphamide), followed by highdose chemotherapy using etoposide, carboplatin, and melphalan with autologous hematopoietic stem cell transplantation (SCT). Two patients have been alive without any evidence of disease for 30 and 37 months after diagnosis, respectively, and require no medication. Consolidation with SCT should be further studies for selected patients with high-risk MRTK.

UR - http://www.scopus.com/inward/record.url?scp=67650499564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650499564&partnerID=8YFLogxK

U2 - 10.1002/pbc.21958

DO - 10.1002/pbc.21958

M3 - Article

VL - 52

SP - 888

EP - 890

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 7

ER -